Evidence map›Paper›PMID 38665514›Full record

ArticleChemical science2024

Visible-light-driven alkene dicarboxylation with formate and CO

Fulin Zhang, Xiao-Yang Wu, Pan-Pan Gao, Hao Zhang, Zhu Li, Shangde Ai, Gang Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Alkene Carboxy-Alkylation via COJournal of the American Chemical Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fulin ZhangFrontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Zhang Jiang Institute for Advanced Study, Shanghai Jiao Tong University Shanghai 200240 China gang.li@sjtu.edu.cn.
Xiao-Yang WuFrontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Zhang Jiang Institute for Advanced Study, Shanghai Jiao Tong University Shanghai 200240 China gang.li@sjtu.edu.cn.
Pan-Pan GaoFrontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Zhang Jiang Institute for Advanced Study, Shanghai Jiao Tong University Shanghai 200240 China gang.li@sjtu.edu.cn.
Hao ZhangFrontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Zhang Jiang Institute for Advanced Study, Shanghai Jiao Tong University Shanghai 200240 China gang.li@sjtu.edu.cn.
Zhu LiFrontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Zhang Jiang Institute for Advanced Study, Shanghai Jiao Tong University Shanghai 200240 China gang.li@sjtu.edu.cn.
Shangde AiFrontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Zhang Jiang Institute for Advanced Study, Shanghai Jiao Tong University Shanghai 200240 China gang.li@sjtu.edu.cn.
Gang LiFrontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Zhang Jiang Institute for Advanced Study, Shanghai Jiao Tong University Shanghai 200240 China gang.li@sjtu.edu.cn.ORCID https://orcid.org/0000-0001-5229-554X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low-cost formate salt was used as the reductant and part of the carboxyl source in a visible-light-driven dicarboxylation of diverse alkenes, including simple styrenes. The highly competing hydrocarboxylation side reaction was successfully overridden. Good yields of products were obtained under mild reaction conditions at ambient temperature and pressure of CO

Identifiers

PMID38665514
PMCPMC11041354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.